LOI
Ryan Allway April 10th, 2024 News, Top News, Top Story April 10, 2024 7:45 AM EDT | Source: PharmaCielo Ltd. The proposed acquisition of Siam Ventures, which provides contract manufacturing services through a subsidiary, will act as a gateway to large Asian markets for PharmaCielo product. Experienced investor, businessman and... Read more
EGF Theramed Has Signed Its First Non-Binding LOI to Aquire Its First Cannabis Dispensary
Ryan Allway February 8th, 2023 News, Top News Vancouver, British Columbia–(Newsfile Corp. – February 8, 2023) – EGF Theramed Health Corp. (CSE: TMED) (OTC Pink: EVAHF) (FSE: AUH) (the “Company” of “EGF“) is pleased to announce it has progressed forward and is now very close to acquiring various dispensary targets in... Read more
Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific
Ryan Allway January 27th, 2023 News, Top News Strategic transaction assembles an experienced management and scientific team world-renowned in mental health treatment, research and development Establishes large footprint of 17 specialized mental health clinics across North America, enhanced by a telehealth platform expected to extend access to critical treatments... Read more
SciSparc Enters Into Non-Binding Letter of Intent to Sell a 50% interest in its Subsidiary that Owns an Amazon Top Seller Brand
Ryan Allway December 14th, 2022 News, Top News TEL AVIV, Israel, Dec. 14, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that it has entered... Read more
Cann American Corp. Announces Binding Letter of Intent
Ryan Allway October 26th, 2022 News, Top News CLOVERDALE, CA / ACCESSWIRE / October 26, 2022 / Cann American Corp. (OTC PINK:CNNA), the “Company”, a holding company building a diverse portfolio of intellectual properties, is pleased to announce the Company has entered into a binding letter of intent (“LOI”). Cann... Read more
Silo Wellness Announces LOI for Potentially Largest Psilocybin Retreat Center in Oregon and the World – If November’s Election Is Favorable; and an Oregon Real Estate Law and Psilocybin Industry Primer
Ryan Allway October 20th, 2022 Psychedelics, Top News Springfield, Oregon–(Newsfile Corp. – October 20, 2022) – Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K7A) (“Silo Wellness” or the “Company”), Oregon’s only publicly traded psychedelics company, is pleased to announce it has executed a binding term sheet for a joint venture... Read more
Grapefruit USA, Inc. Executes Binding Letter of Intent to Acquire Diagnostic Lab Corporation, Inc., Secure New Financing
Ryan Allway July 6th, 2022 News, Top News LOS ANGELES and DESERT HOT SPRINGS, Calif., July 06, 2022 (GLOBE NEWSWIRE) —  via InvestorWire — Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, announces today the execution of a binding letter of intent (“LOI”),... Read more
Apple Rush Company, Inc. announces signing of LOI to acquire Lena Brewing providing a critical piece of our seed to sale initiative
Ryan Allway June 2nd, 2022 News, Top News TITUSVILLE, Fla., June 2, 2022 /PRNewswire/ — The Apple Rush Company, Inc. (OTC PINK: APRU) (the “company”) has signed a letter of intent to acquire Lena Beverage, LLC.  Lena Beverage is a craft brewing operation with licensing for beer, alcohol, and hemp production.  The transaction will be... Read more
MJ Harvest, Inc. Announces a Letter of Intent to Merge with Cannabis Sativa Inc.
Ryan Allway May 11th, 2022 News, Top News LAS VEGAS, NV / ACCESSWIRE / May 11, 2022 / MJ Harvest, Inc. (“MJHI”) (OTCQB:MJHI) announced that it has signed a Letter of Intent (“LOI”) to merge with and into Cannabis Sativa, Inc. The LOI provides for MJHI shareholders to receive 2.7... Read more
Halo Collective Signs a Letter of Intent to Acquire Phytocann Group, a Leading European Wellness CBD Company
Phytocann’s audited 2020 revenue and earnings before taxes, depreciation, and amortization (“EBITDA”) were approximately €5.3 million and €1.2 million, respectively, for the twelve-month period ended December 31, 20201. Phytocann is expected publish audited numbers for the period ended December 31, 2021 within the next 90 days. After the Planned Acquisition is completed,... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )